Search - tctmd.com

Displaying 401 - 420 of 446

Sort: Relevancy | Date

News Daily News

Not Just Where but When: Public Access to Defibrillators Isn’t Round the Clock

Caitlin E. Cox

August 22, 2016

News Daily News

Neighborhood Access to Healthy Food Affects Residents’ Risk of Atherosclerosis

Leah Lawrence

August 22, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

Shelley Wood

July 28, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

Michael O'Riordan

June 24, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

News Daily News

New Guidance Offers Hands-on, Big-Picture Approach to Preparticipation CV Screening

Shelley Wood

April 19, 2016

News Conference News ACC 2016

Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why

Yael L. Maxwell

April 06, 2016

News Conference News ACC 2016

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Michael O'Riordan

April 03, 2016

News Daily News

¿Relaja el Acuerdo de la FDA con Amarin el Control de las Promociones Fuera de Indicación?

Michael O'Riordan

March 09, 2016

News Daily News

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Michael O'Riordan

March 09, 2016

News Daily News

FDA 与阿玛琳之间的和解是否会减弱该局对标签外用途推广的监督？

Michael O'Riordan

March 09, 2016

News Daily News

Hemodynamic Guidance of Hydration Cuts Contrast Nephropathy in Patients With Kidney Disease, Heart Failure

Todd Neale

December 09, 2015

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Daily News

没有钱就得不到药物：全球范围内心血管疾病二级预防的障碍

Caitlin E. Cox

October 27, 2015

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

Advertisement

Not Just Where but When: Public Access to Defibrillators Isn’t Round the Clock

Neighborhood Access to Healthy Food Affects Residents’ Risk of Atherosclerosis

TCTMD’s Top 10 Most Popular Stories for July 2016

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

TCTMD’s Top 10 Most Popular Stories for May 2016

New Guidance Offers Hands-on, Big-Picture Approach to Preparticipation CV Screening

Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

¿Relaja el Acuerdo de la FDA con Amarin el Control de las Promociones Fuera de Indicación?

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

FDA 与阿玛琳之间的和解是否会减弱该局对标签外用途推广的监督？

Hemodynamic Guidance of Hydration Cuts Contrast Nephropathy in Patients With Kidney Disease, Heart Failure

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

没有钱就得不到药物：全球范围内心血管疾病二级预防的障碍

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content